Fortitude Family Office’s Avidity Biosciences RNAM Stock Holding History

Fortitude Family Office’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6	Closed	-$433	–	2043
2025 Q4	$433	Hold	6	–	–	﹤0.01%	1759
2025 Q3	$261	Buy	+6	New	+$243	﹤0.01%	1914

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Fortitude Family Office's RNAM Position: Q1 2026 in Review

Fortitude Family Office sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 6 shares — an estimated $433 sold.

Fortitude Family Office first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $433 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Fortitude Family Office reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Fortitude Family Office sold 6 Avidity Biosciences shares in Q1 2026, an estimated $433.
Fortitude Family Office first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Fortitude Family Office's Avidity Biosciences position peaked at $433 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.